Positron Corporation (OTCBB:POSC), a molecular imaging and solutions company specializing in Nuclear Cardiology and a leader in Cardiac PET, announces that due to a greater demand for the Attrius™ PET scanner, the Company has recently begun increasing production capacities with its joint venture, Neusoft Positron Medical Systems.Positron’s award-winning, cardiac optimized PET scanner, the Attrius™, is the only advanced, dedicated, cost-effective PET scanner in the marketplace. The introduction of the Attrius™ last year has generated excitement throughout the cardiac molecular imaging industry. Facilitated by the increase in reimbursement for cardiac PET and an industry-wide movement to better and more efficient medical

More...